Tanaka F, Komi R, Nakamura M, et al. - To clarify if electrocardiography-derived left ventricular hypertrophy (LVH)(ECG-LVH) holds prognostic significance among patients with various degrees of chronic kidney disease (CKD) and affords an improved cardiovascular risk stratification based on traditional risk factors, researchers undertook this inquiry among 7,206 participants from a general population. The participants were at least 40 years of age, free from cardiovascular events, and were observed for the incidence of cardiovascular events. Following an average 11.3 years of follow-up, a significant increase in the adjusted hazard ratio for the incidence of cardiovascular events was noted for ECG-LVH as per the Sokolow—Lyon voltage, Cornell voltage, or Cornell voltage product in participants suffering from CKD, vs those without CKD. In patients with CKD stage 1–5, ECG-LVH was shown to be beneficial for predicting the risk of future cardiovascular events as well as contributed prognostic information to traditional cardiovascular risk evaluations.